Exxaro Tiles, three others get a warm response on Day 1 of IPO – Mint

The Exxaro IPO was oversubscribed by 4.67 times, followed by Windlas Biotech at 3.18 times, Devyani International at 2.69 times and Krsnaa Diagnostics at 1.98 times, exchange data showed.

Exxaro received bids for 53.5 million equity shares against an IPO size of 11.4 million shares, subscription data available on the exchanges showed. The portion set aside for retail investors was subscribed 9.29 times, while shares reserved for non-institutional investors was subscribed 65%. Employees subscribed 74% of the shares on offer, while qualified institutional buyers have put in bids for 1.11 times the reserved portion.

The ₹1,838-crore IPO of Devyani International received bids for 302.36 million shares, against the issue size of 112.57 million shares. The retail investors’ portion was subscribed 11.36 times. The portion set aside for non-institutional investors was subscribed 77% while that of the employees was subscribed 1.56 times. Qualified institutional buyers have put in bids for 77% of the reserved portion.

The Windlas Biotech offer received bids for 19.4 million shares against the IPO size of 6.14 million equity shares, subscription data available on the exchanges showed. The portion set aside for retail investors was subscribed 6.22 times, while non-institutional investors subscribed only 34% of the shares on offer. Qualified institutional investors are yet to put in their bids for the public issue.

Krsnaa Diagnostics received bids for 14.1 million equity shares on the first day against the offer size of 7.11 equity shares, subscription data available on the exchanges showed.

The retail investors’ portion was oversubscribed by 9.59 times, while the non-institutional investors’ portion was subscribed 15%, and qualified institutional investors bought 48% of their reserved portion